CLINICAL_TRIALS
trial_result
· 2019-10-10
Clinical Trial Update: Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPD [Phase 2]
Summary
Phase 2 trial update evaluating the bronchodilator effect of RPL554 added to tiotropium/olodaterol in COPD patients; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Verona Pharma plc | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2019-10-10